{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:12:31Z","timestamp":1761718351219,"version":"3.28.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To develop and manufacture both immediate and sustained release vaginal tablets containing the anticancer drug disulfiram, which has the potential to be used as a non-invasive treatment for cervical cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Disulfiram-loaded vaginal tablets were manufactured at pilot scale using the direct compression method. These tablets were tested in accordance with the European Pharmacopeia testing of solid dosage form guidelines. They were also tested using a biorelevant dissolution method as well as a dual-chambered release model designed to better mimic the dynamic nature of the vaginal vault.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>We have developed both immediate and sustained release vaginal tablets, which when manufactured at pilot scale are within the limits set by the European Pharmacopeia for the testing of solid dosage forms. Furthermore, these tablets are capable of releasing disulfiram in vitro using the dual-chambered release model at levels 25 000 times and 35 000 times greater than its IC50 concentration for the HeLa cervical cancer cell line.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The successful pilot manufacture and testing of both the immediate and sustained release disulfiram-loaded vaginal tablets warrant further investigation, using an in-vivo model, to assess their potential for use as a non-invasive treatment option for cervical cancer.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jphp.12330","type":"journal-article","created":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T14:30:02Z","timestamp":1418221802000},"page":"189-198","source":"Crossref","is-referenced-by-count":23,"title":["Disulfiram-loaded immediate and extended release vaginal tablets for the localised treatment of cervical cancer"],"prefix":"10.1093","volume":"67","author":[{"given":"Clara S","family":"Baffoe","sequence":"first","affiliation":[{"name":"School of Pharmacy, University of Wolverhampton , Wolverhampton,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nhi","family":"Nguyen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Wolverhampton , Wolverhampton,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Boyd","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Medical Biology Centre, Queen's University of Belfast , Belfast,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguang","family":"Wang","sequence":"additional","affiliation":[{"name":"Research Institute in Healthcare Science, Faculty of Science and Engineering, University of Wolverhampton , Wolverhampton,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Morris","sequence":"additional","affiliation":[{"name":"Research Institute in Healthcare Science, Faculty of Science and Engineering, University of Wolverhampton , Wolverhampton,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"McConville","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Wolverhampton , Wolverhampton,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,2,1]]},"reference":[{"key":"2024103012484590200_jphp12330-cit-0001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2012.03.047","article-title":"Susceptibility to cervical cancer: an overview","volume":"126","author":"de Freitas","year":"2012","journal-title":"Gynecol Oncol"},{"key":"2024103012484590200_jphp12330-cit-0002","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00130404-200309000-00004","article-title":"The epidemiology of cervical cancer","volume":"9","author":"Franco","year":"2009","journal-title":"Cancer J"},{"key":"2024103012484590200_jphp12330-cit-0003","first-page":"240","article-title":"Cervical cancer: a preventable death","volume":"2","author":"Nour","year":"2009","journal-title":"Rev Obstet Gynecol"},{"key":"2024103012484590200_jphp12330-cit-0004","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/cncr.25065","article-title":"Cervical cancer prevention: new tools and old barriers","volume":"116","author":"Scarinci","year":"2010","journal-title":"Cancer"},{"key":"2024103012484590200_jphp12330-cit-0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.apme.2012.05.005","article-title":"HPV vaccine: a breakthrough in prevention of cervical cancer","volume":"9","author":"Sharma","year":"2012","journal-title":"Apollo Medicine"},{"key":"2024103012484590200_jphp12330-cit-0006","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bpobgyn.2011.08.001","article-title":"Cytological screening for cervical cancer prevention","volume":"26","author":"Denny","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2024103012484590200_jphp12330-cit-0007","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffma","year":"2007","journal-title":"Lancet"},{"key":"2024103012484590200_jphp12330-cit-0008","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajog.2011.01.033","article-title":"Treating cervical cancer: breast and cervical cancer prevention and treatment act patients","volume":"204","author":"Chien","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2024103012484590200_jphp12330-cit-0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2011.11.031","article-title":"Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers","volume":"159","author":"Wolinsky","year":"2012","journal-title":"J Control Release"},{"key":"2024103012484590200_jphp12330-cit-0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13346-011-0024-4","article-title":"Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections","volume":"1","author":"Friend","year":"2011","journal-title":"Drug Deliv Transl Res"},{"key":"2024103012484590200_jphp12330-cit-0011","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13346-011-0031-5","article-title":"Ethylene vinyl acetate intravaginal rings for the simultaneous delivery of the antiretroviral UC781 and contraceptive levonorgestrel","volume":"1","author":"Loxley","year":"2011","journal-title":"Drug Deliv Transl Res"},{"key":"2024103012484590200_jphp12330-cit-0012","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jac\/dki326","article-title":"Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings","volume":"56","author":"Malcolm","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2024103012484590200_jphp12330-cit-0013","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13346-012-0101-3","article-title":"Development of a UC781 releasing poly ethylene vinyl acetate vaginal ring","volume":"2","author":"McConville","year":"2012","journal-title":"Drug Deliv Transl Res"},{"key":"2024103012484590200_jphp12330-cit-0014","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jps.23528","article-title":"Preformulation and development of a once-daily sustained-release tenofovir vaginal tablet containing a single excipient","volume":"102","author":"McConville","year":"2013","journal-title":"J Pharm Sci"},{"key":"2024103012484590200_jphp12330-cit-0015","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jac\/dks422","article-title":"Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques","volume":"68","author":"Malcolm","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2024103012484590200_jphp12330-cit-0016","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Karim","year":"2010","journal-title":"Science"},{"key":"2024103012484590200_jphp12330-cit-0017","first-page":"395","article-title":"Vagina and uterus as drug-absorbing organs","volume-title":"Enhancement in Drug Delivery","author":"Malcolm","year":"2006","edition":"7th edn"},{"key":"2024103012484590200_jphp12330-cit-0018","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v17.i5.30","article-title":"Drug delivery by the intravaginal route","volume":"17","author":"Woolfson","year":"2000","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"2024103012484590200_jphp12330-cit-0019","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0168-3659(95)00018-4","article-title":"A bioadhesive patch cervical drug delivery system for the administration of 5-fluorouracil to cervical tissue","volume":"35","author":"Woolfson","year":"1995","journal-title":"J Control Release"},{"key":"2024103012484590200_jphp12330-cit-0020","first-page":"192","article-title":"Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap","volume":"145","author":"Graham","year":"1986","journal-title":"West J Med"},{"key":"2024103012484590200_jphp12330-cit-0021","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-0528.1985.tb01096.x","article-title":"Topical 5-fluorouracil in the treatment of vaginal intraepithelial neoplasia","volume":"92","author":"Kirwan","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"2024103012484590200_jphp12330-cit-0022","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2006.08.014","article-title":"Cervical cancer treatment with a locally insertable controlled release delivery system","volume":"115","author":"Keskar","year":"2006","journal-title":"J Control Release"},{"key":"2024103012484590200_jphp12330-cit-0023","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2012.07.097","article-title":"Localized delivery of chemotherapy to the cervix for radiosensitization","volume":"127","author":"Hodge","year":"2012","journal-title":"Gynecol Oncol"},{"key":"2024103012484590200_jphp12330-cit-0024","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bcp.2006.08.016","article-title":"Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients","volume":"73","author":"Wickstr\u00f6m","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"2024103012484590200_jphp12330-cit-0025","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2011.126","article-title":"Disulfiram modulated ROS\u2013MAPK and NFkB pathways and targeted breast cancer cells with cancer stem cell-like properties","volume":"104","author":"Yip","year":"2011","journal-title":"Br J Cancer"},{"key":"2024103012484590200_jphp12330-cit-0026","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/bjc.2012.442","article-title":"Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells","volume":"107","author":"Liu","year":"2012","journal-title":"Br J Cancer"},{"key":"2024103012484590200_jphp12330-cit-0027","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","article-title":"Disulfiram, a clinically used anti-alcoholism drug and copper-Binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res"},{"key":"2024103012484590200_jphp12330-cit-0028","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1158\/1078-0432.CCR-09-1035","article-title":"High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth","volume":"15","author":"Iljin","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2024103012484590200_jphp12330-cit-0029","doi-asserted-by":"crossref","first-page":"e51470","DOI":"10.1371\/journal.pone.0051470","article-title":"Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells","volume":"7","author":"Ketola","year":"2012","journal-title":"PLoS ONE"},{"key":"2024103012484590200_jphp12330-cit-0030","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1349-7006.1999.tb00722.x","article-title":"Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways","volume":"90","author":"Minagawa","year":"1999","journal-title":"Jpn J Cancer Res"},{"key":"2024103012484590200_jphp12330-cit-0031","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1158\/1535-7163.1049.3.9","article-title":"Disulfiram inhibits activating transcription factor\/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease","volume":"3","author":"Brar","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"2024103012484590200_jphp12330-cit-0032","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01877380","article-title":"Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study","volume":"6","author":"Dufour","year":"1993","journal-title":"Biotherapy"},{"key":"2024103012484590200_jphp12330-cit-0033","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000421-199004000-00007","article-title":"A randomized phase II study of cisplatin alone versus cisplatin plus disulfiram","volume":"13","author":"Verma","year":"1990","journal-title":"Am J Clin Oncol"},{"key":"2024103012484590200_jphp12330-cit-0034","first-page":"197","article-title":"Disulfiram induces apoptosis in human melanoma cells: a redox-related process","volume":"1","author":"Cen","year":"2002","journal-title":"Molecular Cancer Ther"},{"key":"2024103012484590200_jphp12330-cit-0035","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1021\/jm049568z","article-title":"Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells","volume":"47","author":"Cen","year":"2004","journal-title":"J Med Chem"},{"key":"2024103012484590200_jphp12330-cit-0036","first-page":"217","article-title":"Copper","volume":"37","author":"Barceloux","year":"1999","journal-title":"J Toxicol"},{"key":"2024103012484590200_jphp12330-cit-0037","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/abbi.1998.0618","article-title":"Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species","volume":"353","author":"Burkitt","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"2024103012484590200_jphp12330-cit-0038","doi-asserted-by":"crossref","first-page":"26202","DOI":"10.1074\/jbc.270.44.26202","article-title":"Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper","volume":"270","author":"Nobel","year":"1995","journal-title":"J Biol Chem"},{"key":"2024103012484590200_jphp12330-cit-0039","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.exer.2006.04.010","article-title":"ALDH3A1: a corneal crystallin with diverse functions","volume":"84","author":"Estey","year":"2007","journal-title":"Exp Eye Res"},{"key":"2024103012484590200_jphp12330-cit-0040","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.cdd.4401830","article-title":"Reactive oxygen species mediate crosstalk between NF-kappaB and JNK","volume":"13","author":"Nakano","year":"2006","journal-title":"Cell Death Differ"},{"key":"2024103012484590200_jphp12330-cit-0041","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ijc.10972","article-title":"Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines","volume":"104","author":"Wang","year":"2003","journal-title":"Int J Cancer"},{"key":"2024103012484590200_jphp12330-cit-0042","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canlet.2009.09.002","article-title":"Disulfiram\/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines","volume":"290","author":"Guo","year":"2009","journal-title":"Cancer Lett"},{"key":"2024103012484590200_jphp12330-cit-0043","first-page":"4435","article-title":"Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay","volume":"49","author":"Plumb","year":"1989","journal-title":"Cancer Res"},{"key":"2024103012484590200_jphp12330-cit-0044","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1074\/jbc.R800055200","article-title":"New roles for copper metabolism in cell proliferation, signalling and disease","volume":"284","author":"Turski","year":"2009","journal-title":"J Biol Chem"},{"key":"2024103012484590200_jphp12330-cit-0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0378-5173(03)00142-X","article-title":"Note of the measurement of flowability according to the European Pharmacopeia","volume":"257","author":"Schussele","year":"2003","journal-title":"Int J Pharm"},{"key":"2024103012484590200_jphp12330-cit-0046","doi-asserted-by":"crossref","first-page":"994","DOI":"10.17485\/ijst\/2010\/v3i9.10","article-title":"Formulation of ferrous fumarate (combination) tablets by using a direct-compression method","volume":"3","author":"Sultana","year":"2010","journal-title":"Indian J Sci Technol"},{"key":"2024103012484590200_jphp12330-cit-0047","first-page":"163","article-title":"Evaluating flow properties of solids","volume":"72","author":"Carr","year":"1965","journal-title":"Chem Eng"},{"key":"2024103012484590200_jphp12330-cit-0048","first-page":"38","article-title":"Developments in powder flow testing","volume":"30","author":"Rios","year":"2006","journal-title":"Pharm Technol"},{"volume-title":"Chapter 1174, powder flow","author":"United States Pharmacopeia","key":"2024103012484590200_jphp12330-cit-0049"},{"key":"2024103012484590200_jphp12330-cit-0050","first-page":"349","article-title":"The effects of lactose, microcrystalline cellulose and dicalcium phosphate on swelling and erosion of compressed HPMC matrix tablets: texture analyzer","volume":"9","author":"Tukarama","year":"2010","journal-title":"Iran J Pharm Res"},{"key":"2024103012484590200_jphp12330-cit-0051","first-page":"299","article-title":"Vaginal changes with aging","volume-title":"The Gynecologist and the Older Patient","author":"Bergh","year":"1988","edition":"1st edn"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.12330","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.12330","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/67\/2\/189\/60227870\/jphp12330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/67\/2\/189\/60227870\/jphp12330.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T18:11:23Z","timestamp":1730311883000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/67\/2\/189\/6128027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,1]]},"published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jphp.12330","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"type":"electronic","value":"2042-7158"},{"type":"print","value":"0022-3573"}],"subject":[],"published-other":{"date-parts":[[2015,2]]},"published":{"date-parts":[[2015,2,1]]}}}